244 related articles for article (PubMed ID: 21694443)
21. Intrarenal expression of microRNAs in patients with IgA nephropathy.
Wang G; Kwan BC; Lai FM; Choi PC; Chow KM; Li PK; Szeto CC
Lab Invest; 2010 Jan; 90(1):98-103. PubMed ID: 19901913
[TBL] [Abstract][Full Text] [Related]
22. Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN.
Cao Y; Wang Y; Liu Y; Zhu X; Zhang G; Wang S; Chen X; Liu D; Fu C
Dis Markers; 2019; 2019():2424751. PubMed ID: 31485275
[TBL] [Abstract][Full Text] [Related]
23. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy.
Ranieri E; Gesualdo L; Petrarulo F; Schena FP
Kidney Int; 1996 Dec; 50(6):1990-2001. PubMed ID: 8943482
[TBL] [Abstract][Full Text] [Related]
24. Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease.
Szeto CC; Ng JK; Fung WW; Chan GC; Luk CC; Lai KB; Wang G; Chow KM; Mac-Moune Lai F
Clin Chim Acta; 2022 May; 530():81-86. PubMed ID: 35278407
[TBL] [Abstract][Full Text] [Related]
25. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
26. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
[TBL] [Abstract][Full Text] [Related]
27. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
[TBL] [Abstract][Full Text] [Related]
28. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
Feng Y; Lv LL; Wu WJ; Li ZL; Chen J; Ni HF; Zhou LT; Tang TT; Wang FM; Wang B; Chen PS; Crowley SD; Liu BC
Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333
[TBL] [Abstract][Full Text] [Related]
29. TWEAK/Fn14 system and crescent formation in IgA nephropathy.
Sasaki Y; Shimizu Y; Suzuki Y; Horikoshi S; Tomino Y
BMC Nephrol; 2015 Mar; 16():27. PubMed ID: 25885587
[TBL] [Abstract][Full Text] [Related]
30. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
[TBL] [Abstract][Full Text] [Related]
32. Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy.
Cox SN; Chiurlia S; Divella C; Rossini M; Serino G; Bonomini M; Sirolli V; Aiello FB; Zaza G; Squarzoni I; Gangemi C; Stangou M; Papagianni A; Haas M; Schena FP
Sci Rep; 2020 Sep; 10(1):15164. PubMed ID: 32938960
[TBL] [Abstract][Full Text] [Related]
33. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.
Liu LL; Jiang Y; Wang LN; Liu N
Clin Exp Immunol; 2012 Aug; 169(2):148-55. PubMed ID: 22774989
[TBL] [Abstract][Full Text] [Related]
34. Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy.
Zhao S; Sun Y; Mao Q; Zhou C; Chen Y; Xue D
Nephron; 2022; 146(6):539-552. PubMed ID: 35381590
[TBL] [Abstract][Full Text] [Related]
35. Altered mRNA expression in renal biopsy tissue from patients with IgA nephropathy.
Waga I; Yamamoto J; Sasai H; Munger WE; Hogan SL; Preston GA; Sun HW; Jennette JC; Falk RJ; Alcorta DA
Kidney Int; 2003 Oct; 64(4):1253-64. PubMed ID: 12969143
[TBL] [Abstract][Full Text] [Related]
36. Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis.
Wang G; Kwan BC; Lai FM; Chow KM; Li PK; Szeto CC
Am J Nephrol; 2012; 36(5):412-8. PubMed ID: 23108026
[TBL] [Abstract][Full Text] [Related]
37. Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?
Ciferska H; Honsova E; Lodererova A; Hruskova Z; Neprasova M; Vachek J; Suchanek M; Zima T; Coppo R; Tesar V; Novak J; Maixnerova D
J Nephrol; 2020 Apr; 33(2):307-316. PubMed ID: 31489594
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
Yoon SY; Kim JS; Jung SW; Kim YG; Hwang HS; Moon JY; Lee SH; Seo JW; Seok J; Tae D; Jeong K
Sci Rep; 2023 Oct; 13(1):17201. PubMed ID: 37821628
[TBL] [Abstract][Full Text] [Related]
39. Lower urinary-interleukin-1 receptor-antagonist excretion in IgA nephropathy than in Henoch-Schönlein nephritis.
Rauta V; Teppo AM; Törnroth T; Honkanen E; Grönhagen-Riska C
Nephrol Dial Transplant; 2003 Sep; 18(9):1785-91. PubMed ID: 12937225
[TBL] [Abstract][Full Text] [Related]
40. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
Hu H; Wan Q; Li T; Qi D; Dong X; Xu Y; Chen H; Liu H; Huang H; Wei C; Zhou W; Jiang S; Mo Z; Liao F; Xu Q; He Y
Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
